Source: ERJ Open Res, 5 (4) 00094-2019; 10.1183/23120541.00094-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nynke A. Kampstra, Paul B. van der Nat, Lea M. Dijksman, Frouke T. van Beek, Daniel A. Culver, Robert P. Baughman, Elisabetta A. Renzoni, Wim Wuyts, Vasilis Kouranos, Pieter Zanen, Marlies S. Wijsenbeek, Marinus J.C. Eijkemans, Douwe H. Biesma, Philip J. van der Wees, Jan C. Grutters. Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes. ERJ Open Res, 5 (4) 00094-2019; 10.1183/23120541.00094-2019

Member's Comments

No comment yet.

Related content which might interest you: Maintenance after pulmonary rehabilitation in COPD: a randomised trial. Preliminary results Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004 Prognostic factors of pulmonary embolism: results of a prospective multicenter study Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Preliminary results of pulmonary rehabilitation in interstitial lung diseases: A randomised controlled trial B32220095560 Source: Annual Congress 2011 - Exercise training: new populations, new techniques Year: 2011 Comparison of Interferon gamma-1b (IFN-γ)and colcicine in the treatment of Idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomised study Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002 The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019 Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021 Year: 2022 Interim results on European multi-center trial to evaluate the clinical utility of arteriovenous fistulae for treatment of severe COPD Source: Annual Congress 2010 - Interventions for obstructive lung diseases Year: 2010 A prospective study comparing the repeatability and sensitivity to change of non-invasive endpoints in pulmonary arterial hypertension: the RESPIRE study Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Lung volume reduction coil treatment for patients with emphysema: 6-month multicenter feasibility results Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 Preliminary results of a multicenter study for home treatment of pulmonary embolism (PE) Source: Eur Respir J 2006; 28: Suppl. 50, 365s Year: 2006 A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019 Year: 2019 A multicentre observational study of the prevalence, management and outcomes of subsegmental pulmonary embolism Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Clinical features of autoimmune pulmonary alveolar proteinosis from a large international patient cohort: baseline data from the IMPALA trial Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study Source: Eur Respir J, 53 (3) 1802093; 10.1183/13993003.02093-2018 Year: 2019 Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study Source: Eur Respir J, 51 (4) 1702037; 10.1183/13993003.02037-2017 Year: 2018